Structure-based engineering of immune cytokine signaling
Structure-based engineering of immune cytokine signaling
批准号:
10717246
负责人:
Kenan Christopher GARCIA
金额:
$51.78万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
未结题
起止时间:
2002-04-01 至 2028-06-30
关键词:
3-DimensionalAddressAgonistAntineoplastic AgentsArchitectureAwardBindingBiologicalCD8B1 geneCellsChemistryComplexCryoelectron MicroscopyCytokine ReceptorsCytokine SignalingDimerizationDose LimitingEngineeringG-Protein-Coupled ReceptorsGrantHandHomeostasisHomoImageImmuneImmune systemImmunotherapeutic agentInterferonsInterleukin 2 ReceptorInterleukin 2 Receptor GammaInterleukin-10Interleukin-12Interleukin-2JAK1 geneJAK3 geneJanus kinaseKnowledgeLengthLigandsMalignant NeoplasmsMediatingMembraneMolecularMusNatural Killer CellsOutcomePaintPatternPharmaceutical PreparationsPlayPropertyProtein EngineeringReceptor SignalingReportingRoleSignal TransductionSpecificityStructureStructure-Activity RelationshipSystemT-LymphocyteTherapeuticToxic effectTranslationsVariantanalogantitumor agentantitumor effectcancer immunotherapeuticscancer immunotherapycancer therapycell typecytokinedesignexhaustionextracellularfightingimmunoengineeringimmunoregulationimprovedin vivointerleukin-12 receptorinterleukin-21interleukin-22interleukin-23leukocyte proliferationnanobodiespharmacologicpleiotropismpreferencereceptorreconstitutionstemnessstructural biologysystemic toxicitytranslational barriertumortumor immunology
中文摘要
文摘:
英文摘要
ABSTRACT:
Immunoregulatory cytokines engage transmembrane signaling receptors in order to mediate a wide range of
functions including leukocyte proliferation, differentiation, and expansion through JAK/STAT activation. Most
immunoregulatory cytokines possess both redundant and distinct activities that are critical to normal immune
homeostasis, but this functional pleiotropy presents a major problem for the effective use of these cytokines as
immunotherapeutic cancer drugs. Cytokine pleiotropy is a consequence of different cytokine receptors being
expressed on multiple different counterbalancing cell types that serves to neutralize anti-tumor actions and lead
to systemic toxicity. During the prior term of this award, we gained an appreciation for the extracellular
structural architectures of a spectrum of different immune cytokine complexes, including those of IL-2, IL-10,
IL-12, IL-21, IL-22, IL-23, IL-27, IFN, and IFN. In this renewal application, with these structural templates in
hand, in Aim 1 we focus our studies on the cytokines IL-2, IFN, and IL-12. These immune master regulators
engage different but overlapping branches of the immune system, and share the issues of pleiotropy and toxicity
that, if uncoupled, could lead to powerful cancer immunotherapeutic agents. We propose to “tune” signaling
through structure-based cytokine engineering to attempt to create variants with decoupled pleiotropy, cell subset
preferences, enhanced anti-tumor efficacies, and reduced toxicity – both alone and in combination. In Aim 2, we
wish to understand the mechanistic basis for how tuned cytokines can differentially activate signaling inside the
cells. Based on a recent breakthrough in our 20-year quest to solve the full-length JAK structure, we continue to
pursue structural information on how cytokine binding to their receptors activates Janus Kinase (JAK)
molecules, by reconstituting and imaging activated JAK homo- and heterodimers bound to both cytokine and
intracellular JAKs and STATs. In this fashion, by combining structural biology, protein engineering, cell
signaling, and in vivo tumor studies, we propose to obtain a complete molecular snapshot of cytokine receptor
signaling from the initial engagement of ligand through the activation of intracellular signaling cascades and
leverage this information for the engineering of cancer immunotherapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Global Map of Interactions Among Human Cell Surface Proteins and Secreted Ligands
-
批准号:10710033
-
项目类别:
-
资助金额:$270.14万
-
财政年份:2022
-
负责人:Kenan Christopher GARCIA
-
依托单位:
A Global Map of Interactions Among Human Cell Surface Proteins and Secreted Ligands
-
批准号:10478763
-
项目类别:
-
资助金额:$171.79万
-
财政年份:2022
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy
-
批准号:10176894
-
项目类别:
-
资助金额:$55.4万
-
财政年份:2018
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy
-
批准号:9761520
-
项目类别:
-
资助金额:$69.84万
-
财政年份:2018
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy
-
批准号:10197113
-
项目类别:
-
资助金额:$66.95万
-
财政年份:2018
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Structure-based Bioengineering of Wnt Surrogates for Intestinal Stem Cell Biology and Therapy
-
批准号:10447202
-
项目类别:
-
资助金额:$65.44万
-
财政年份:2018
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Viral GPCR recognition of chemokines and engineered ligands
-
批准号:9298587
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2016
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Viral GPCR recognition of chemokines and engineered ligands
-
批准号:9143553
-
项目类别:
-
资助金额:$39.5万
-
财政年份:2016
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Novel Interferons and small molecule enhancers of the interferon pathway
-
批准号:8643869
-
项目类别:
-
资助金额:$48.43万
-
财政年份:2014
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Engineering of macrophage phagocytosis for cancer and stem cell immunotherapy
-
批准号:8687302
-
项目类别:
-
资助金额:$30.94万
-
财政年份:2014
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Engineering of macrophage phagocytosis for cancer and stem cell immunotherapy
-
批准号:8840913
-
项目类别:
-
资助金额:$33.46万
-
财政年份:2014
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Structural correlates of T cell receptor signaling
-
批准号:10531572
-
项目类别:
-
资助金额:$50.6万
-
财政年份:2013
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Structural correlates of T cell receptor signaling
-
批准号:9185260
-
项目类别:
-
资助金额:$44.39万
-
财政年份:2013
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Structural correlates of T cell receptor signaling
-
批准号:8773573
-
项目类别:
-
资助金额:$45.18万
-
财政年份:2013
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Structural correlates of T cell receptor signaling
-
批准号:10308085
-
项目类别:
-
资助金额:$50.6万
-
财政年份:2013
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Molecular Principles of Wnt-Frizzled Signal Initiation and Inhibition
-
批准号:8451388
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2011
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Molecular Principles of Wnt-Frizzled Signal Initiation and Inhibition
-
批准号:8642191
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2011
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Molecular Principles of Wnt-Frizzled Signal Initiation and Inhibition
-
批准号:8069796
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2011
-
负责人:Kenan Christopher GARCIA
-
依托单位:
Molecular Principles of Wnt-Frizzled Signal Initiation and Inhibition
-
批准号:8245015
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2011
-
负责人:Kenan Christopher GARCIA
-
依托单位:
CHRISTOPHER GARCIA PRT TIME
-
批准号:7370402
-
项目类别:
-
资助金额:$0.41万
-
财政年份:2006
-
负责人:Kenan Christopher GARCIA
-
依托单位:
海外基金